VistaPath Raises $4M in Seed Funding
- VistaPath, a Cambridge, Mass.-based provider of artificial intelligence (AI)-based, data-driven pathology processing platforms, secured $4 million in seed funding
- The round was led by Moxxie Ventures with participation from NextGen Venture Partners and First Star Ventures
- The company intends to use the funds to expand operations and its development efforts
- The company provides Sentinel, a pathology processing platform designed to deliver a range of solutions for critical lab processes
- The company’s first application, released in 2021, is a tissue grossing platform that automates the process of receiving, assessing, and processing tissue samples
